Another indicator illustrating a certain link of prominin-1 and inflammation arises from the observation that treatment of colon cancer in vivo or neuroblastoma cells in vitro with the nonsteroidal anti-inflammatory drug celecoxib or indomethacin decreased the amount of prominin-1–positive tumor cells [75]–[77]. This evidence concerns the gene PROM1 and neuroblastoma.